The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin

NCT06333080 · Terminated

Last updated 2026-05-28

This clinical trial is testing whether taking oral semaglutide regularly improves blood sugar control in adults with type 2 diabetes who are already taking metformin.

Status Terminated Stopped early and will not restart.

Type Observational

Participants 1 person

Who can join Ages 18+ · all sexes

Timeline Started 2023-11 · est. completion 2025-07

Where 1 site · Denmark

What this study is testing ClinicalTrials.gov NCT06333080 ↗

Description as written by the study sponsor.

The objective of the trial is to investigate the effect of adherence to oral semaglutide dosing instructions on glycaemic control in people with type 2 diabetes, which are dysregulated on metformin and naïve to second line antidiabetic treatment.

Main thing measured	Time-in-Range (TIR)
Sponsor	Aalborg University Hospital
Conditions studied	Diabetes Mellitus, Type 2
GLP-1 drugs	semaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT06333080 ↗